赛托生物
(300583)
| 流通市值：28.15亿 | | | 总市值：28.68亿 |
| 流通股本：1.86亿 | | | 总股本：1.90亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 237,227,639.06 | 295,069,867.48 | 228,434,285.54 | 271,715,631.89 |
| 应收票据及应收账款 | 342,731,641.78 | 261,615,773.38 | 234,690,640.95 | 247,179,997.53 |
| 应收账款 | 342,731,641.78 | 261,615,773.38 | 234,690,640.95 | 247,179,997.53 |
| 应收款项融资 | 241,658,350.51 | 223,749,657.31 | 202,580,318.73 | 170,420,065.3 |
| 预付款项 | 7,070,192.69 | 1,572,389.78 | 4,279,257.98 | 9,345,061.59 |
| 其他应收款合计 | 4,195,124.05 | 7,118,053.83 | 7,693,499.1 | 7,806,475.39 |
| 存货 | 395,523,441.42 | 477,238,201.91 | 495,950,182.87 | 515,354,334.55 |
| 合同资产 | - | 0 | - | - |
| 其他流动资产 | 22,666,937.55 | 18,169,621.52 | 16,182,786.22 | 20,293,980.26 |
| 流动资产合计 | 1,251,073,327.06 | 1,284,533,565.21 | 1,189,810,971.39 | 1,242,115,546.51 |
| 非流动资产: | | | | |
| 长期股权投资 | 73,528,766.22 | 71,037,659.02 | 69,939,205.51 | 68,639,229.48 |
| 其他权益工具投资 | 3,000,000 | 3,000,000 | 3,000,000 | - |
| 固定资产 | 1,123,460,579.12 | 1,159,694,702.2 | 1,097,763,737.52 | 1,129,220,114.27 |
| 在建工程 | 273,515,379.15 | 231,256,719.38 | 302,864,587.19 | 279,221,920.31 |
| 使用权资产 | 2,285,480.58 | 2,728,332.52 | 1,607,229.22 | 1,360,368.12 |
| 无形资产 | 182,737,184.31 | 182,858,150.44 | 184,023,854.18 | 185,807,823.45 |
| 长期待摊费用 | 580,177.77 | 614,830.65 | 472,811.93 | - |
| 递延所得税资产 | 16,476,953.29 | 13,110,619.37 | 12,190,685.48 | 12,465,587.25 |
| 其他非流动资产 | 4,989,810.99 | 6,804,978.44 | 4,406,000 | 4,406,000 |
| 非流动资产合计 | 1,680,574,331.43 | 1,671,105,992.02 | 1,676,268,111.03 | 1,681,121,042.88 |
| 资产总计 | 2,931,647,658.49 | 2,955,639,557.23 | 2,866,079,082.42 | 2,923,236,589.39 |
| 流动负债: | | | | |
| 短期借款 | 602,741,810.45 | 609,590,805.2 | 661,216,449.4 | 665,927,402.23 |
| 应付票据及应付账款 | 279,609,001.69 | 292,260,516.91 | 258,700,364.33 | 266,435,685.26 |
| 其中：应付票据 | 107,567,017.27 | 112,181,281.97 | 111,312,158.63 | 97,917,835.58 |
| 应付账款 | 172,041,984.42 | 180,079,234.94 | 147,388,205.7 | 168,517,849.68 |
| 合同负债 | 3,409,346 | 4,707,669.61 | 3,119,274.46 | 5,292,479.25 |
| 应付职工薪酬 | 8,062,719.56 | 11,712,550.52 | 8,007,196.17 | 7,356,878.94 |
| 应交税费 | 21,168,889.67 | 13,189,695.67 | 7,811,293.84 | 9,289,397.23 |
| 其他应付款合计 | 22,222,832.37 | 15,254,406.42 | 16,669,183.58 | 15,933,098.48 |
| 一年内到期的非流动负债 | 47,217,542.9 | 58,690,444.4 | 26,888,824.14 | 37,342,812.33 |
| 其他流动负债 | 350,876.48 | 469,892.39 | 326,592.27 | 536,132.12 |
| 流动负债合计 | 984,783,019.12 | 1,005,875,981.12 | 982,739,178.19 | 1,008,113,885.84 |
| 非流动负债: | | | | |
| 长期借款 | 125,642,638.89 | 133,767,638.89 | 56,800,000 | 64,614,353.04 |
| 租赁负债 | 917,195.24 | 1,116,817.44 | 303,105.4 | 355,127.08 |
| 长期应付款 | - | - | 3,729,952.69 | 7,404,716.96 |
| 递延收益 | 19,038,878.35 | 18,189,027.2 | 20,717,118.03 | 19,743,680.06 |
| 递延所得税负债 | - | - | 547,345.71 | 573,258.27 |
| 非流动负债合计 | 145,598,712.48 | 153,073,483.53 | 82,097,521.83 | 92,691,135.41 |
| 负债合计 | 1,130,381,731.6 | 1,158,949,464.65 | 1,064,836,700.02 | 1,100,805,021.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 189,702,126 | 189,702,126 | 189,702,126 | 189,702,126 |
| 资本公积 | 1,276,956,870.47 | 1,276,956,870.47 | 1,276,956,870.47 | 1,276,956,870.47 |
| 盈余公积 | 97,024,617.14 | 97,024,617.14 | 93,766,209.97 | 93,766,209.97 |
| 未分配利润 | 202,112,967.55 | 198,496,394.41 | 205,672,011.77 | 224,112,175.52 |
| 归属于母公司股东权益合计 | 1,765,796,581.16 | 1,762,180,008.02 | 1,766,097,218.21 | 1,784,537,381.96 |
| 少数股东权益 | 35,469,345.73 | 34,510,084.56 | 35,145,164.19 | 37,894,186.18 |
| 股东权益合计 | 1,801,265,926.89 | 1,796,690,092.58 | 1,801,242,382.4 | 1,822,431,568.14 |
| 负债和股东权益合计 | 2,931,647,658.49 | 2,955,639,557.23 | 2,866,079,082.42 | 2,923,236,589.39 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-29 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |